---
title: Tapping Microbiome Science for New Treatments and Answers to Drug Efficacy
description: Adding microbiome-based evidence to disease modeling will enable the life sciences industry to unlock new potential for stratified treatments.
---

[News](https://www.eaglegenomics.com/news)

# [Tapping Microbiome Science for New Treatments and Answers to Drug Efficacy](https://www.eaglegenomics.com/news/tapping-microbiome-science-for-new-treatments-and-answers-to-drug-efficacy)

 Written by [Admin](https://www.eaglegenomics.com/news/author/admin) | Oct 26, 2020 5:00:00 PM

Anthony Finbow, CEO of Eagle Genomics, talks to Pharm Exec about how adding microbiome-based evidence to disease modeling will enable the life sciences industry to unlock new potential for stratified treatments.

[View full post](https://www.eaglegenomics.com/news/tapping-microbiome-science-for-new-treatments-and-answers-to-drug-efficacy)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Admin"
  },
  "dateModified" : "2022-08-10T10:54:14.809Z",
  "datePublished" : "2020-10-26T17:00:00Z",
  "headline" : "Tapping Microbiome Science for New Treatments and Answers to Drug Efficacy",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1080,
    "url" : "https://2869527.fs1.hubspotusercontent-na1.net/hubfs/2869527/EagleGenomics_PressCoverage_2020-10-26_MicrobiomeDrugEfficacy.png",
    "width" : 1920
  },
  "mainEntityOfPage" : "https://www.eaglegenomics.com/news/tapping-microbiome-science-for-new-treatments-and-answers-to-drug-efficacy",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "2021 News and Blog"
  }
}
```